I-Omega-3 fatty acids yiqela lamafutha e-polyunsaturated, okanye amafutha "amahle", afaka i-docosahexaenoic acid (DHA), i-alpha-linolenic acid (ALA) kunye ne-eicosapentaenoic acid (EPA). Izifundo kubantu abanamazinga aphezulu e-triglyceride baye babonisa ukuba ukuthatha indawo ephakathi kwama-2 no-4 amagremu amafutha e-omega-3 anokukwazi ukunciphisa amazinga e- triglyceride ngama-50%.
Nangona zifumaneka kwiindawo zokutya - ezifana neentlanzi ezithile zeentlanzi kunye ne-nut-omega-3 zamafutha nazo ziyafumaneka kwiimali eziphezulu kwiimveliso ezifumanekayo ezinokufumaneka kwiithalafu zokugcina. Ukongezelela, kukho iipilisi ezimbalwa zonyango eziqulethe i-omega-3 fatty acids, eziquka uLovaza , Vascepa , noEpanova.
Ngazo zonke ezi zikhethi, ziza kuthatha izithako ezongezelelekileyo ezithengisa ii-omega-3 zibe zilungele ukufumana imithi yazo?
Izibonelelo kunye nemigqaliselo equkethe i-omega-3 fatty acids ayiyiyo yonke into eyalinganayo. Bobabini bafumana iimfuno zokubeka esweni ezahlukeneyo ezibekwe nguDiary and Drug Administration (FDA). Iimveliso ezingaphezu kwe-counter-counter, ezifana ne-omega-3 fatty supplements ezitholakala kwiivenkile, zihlelwa njenge "ukutya" yi-FDA. Oku kuthetha ukuba ngumsebenzi womenzi wokuqinisekisa ukuba izongezelelo zikhuselekile, zikhululekile ezingcolileyo, zibhalwe kakuhle kwaye zenziwe kwindawo ekhuselekileyo necocekileyo.
Indlela yodwa i-FDA iya kususa isongezelelo kwiimarike ukuba ngaba kukho izikhalazo zempilo emalunga nemveliso emva kokuba sele ifikelele kwiitrhefu zesitolo.
Ngakolunye uhlangothi, izidakamizwa zamagqabi, zilandelwa kancane ngokuthe ngqo. Ukuze kuvunyelwe ukusetyenziswa njengemithi yonyango, amayeza anama-acids e-omega-3 kufuneka ahlolwe ngokubanzi phambi kokuba anqunywe ngababoneleli bezempilo kwaye bathengiswe kumayeza.
Abavelisi kufuneka baqinisekise kwi-FDA ukuba isichenge sisebenza ngendlela efunekayo ngayo, ukuba ikhuselekile, kwaye ukuba isichengisisi iqulethe zonke izithako ezichazwe kwilebula. Kufuneka baxelele nayiphi na imiphumo emibi efunyanwa ngabantu abathatha imithi.
Omnye umahluko phakathi kwezi ntlobo ezimbini zeemveliso yile nxalenye ye-omega-3 fatty acids. Iyeza zemithi ezinjengeLovaza zinokufikelela kwi-90% ye-omega-3 fatty acids kanti i-add-counter-counter complements iqulethe phakathi kwama-30 no-50% omega-3 fatty acids, kuxhomekeke kwimveliso. Ngoxa i-omega-3 izongezo ziyafumaneka kuluntu jikelele, i-omega-3 fatty acid acills are often used for people in high levels of triglyceride.
Ngenxa yokuba i-omega-3 fatty acid supplements ayifuni ukufumana iimfuno ezivakalayo zokuvavanya ukuba i-omega-3 fatty acids ye-othega-3 yenza ntoni, ayedla kakhulu. Xa kuthatyathwa ngexabiso elilinganayo, i-omega-3 fatty acids yesigxina kunye ne-omega-3 fatty acid supplements kufuneka iyanciphise i-triglycerides ngendlela efanayo.
Ukuba ucinga ukufaka izongezo ze-omega-3 ukuya kwi-regid-downing regimen, kufuneka uqhagamshelane nomboneleli wakho wezempilo.
Nangona zifumaneka ngokukhawuleza, zinokubangela iziphumo ezithile zecala kwaye ziphucule izimo ezithile zonyango.
> Imithombo:
> Ukuvunyelwa kweMithi yenyanga. Iingxelo ze-FDC. I-Chevy Chase, MD 2005; 10 (2): 34.
> Dipiro JT, Talbert RL. I-Pharmacotherapy: Indlela yePathophysiological, 9th 2014.